Cultivating Prognosis Following Percutaneous Coronary Intervention
نویسندگان
چکیده
منابع مشابه
Cultivating Prognosis Following Percutaneous Coronary Intervention
published online Mar 31, 2010; J. Am. Coll. Cardiol. Dean J. Kereiakes Score American College of Cardiology/National Cardiovascular Data Registry Risk Cultivating Prognosis Following Percutaneous Coronary Intervention: The This information is current as of April 1, 2010 http://content.onlinejacc.org/cgi/content/full/j.jacc.2010.02.004v1 located on the World Wide Web at: The online version of th...
متن کاملNoncardiac surgery following percutaneous coronary intervention.
Patient with coronary artery disease (CAD) undergoing major noncardiac surgery (NCS) are at increased risk of serious perioperative cardiac complications. At the same time, safety of percutaneous coronary intervention (PCI) before noncardiac surgery has been questioned. This paper reviews the available literature regarding the safety of PCI before NCS. At the same time, cardiac evaluation befor...
متن کاملRisk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention.
Retroperitoneal hemorrhage (RPH) is a potentially catastrophic complication after percutaneous coronary intervention (PCI). Previous studies identified female gender, body surface area, and high arterial puncture location as independent risk factors for RPH. There have been conflicting reports regarding the association with vascular closure devices (VCDs). Chronic renal insufficiency (CRI) and ...
متن کاملAbciximab reduces mortality in diabetics following percutaneous coronary intervention.
OBJECTIVES We sought to determine whether abciximab therapy at the time of percutaneous coronary intervention (PCI) would favorably affect one-year mortality in patients with diabetes. BACKGROUND Diabetics are known to have increased late mortality following PCI. METHODS Data from three placebo-controlled trials of PCI, EPIC, EPILOG, and EPISTENT, were pooled. The one-year mortality rate fo...
متن کاملProlonged jaundice following percutaneous coronary intervention and ticlopidine therapy.
Ticlopidine, an adenosine diphosphate receptor blocker, is widely used to prevent subacute stent thrombosis after percutaneous coronary intervention. Along with neutropenia and thrombotic thrombocytopenic purpura, cholestatic hepatitis is one of the most serious potential side-effects of ticlopidine therapy. Four patients with prolonged jaundice after ticlopidine therapy, including one fatal ca...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2010
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2010.02.004